Reportee | Signature Date | Report period | Total Entries | Total AUM($) |
---|---|---|---|---|
JOHNSON & JOHNSON INNOVATION - JJDC INC | 08-03-2021 | 06-30-2021 | 21 | 978,187,000 |
Issuer | Class | Position | Value | Shares | Portfolio Percentage (%) | Previous Percentage (%) | Shares Delta | Shares Delta(%) | Date Reported |
---|---|---|---|---|---|---|---|---|---|
FATE THERAPEUTICS, INC. | COM | 1 | $293,269,000 | 3,379,064 | 29.98 | 36.08 | 0 | 0.00 | 06-30-2021 |
ARROWHEAD PHARMACEUTICALS | COM | 2 | $270,065,000 | 3,260,869 | 27.61 | 28.01 | 0 | 0.00 | 06-30-2021 |
PROTAGONIST THERAPEUTICS INC. | COM | 3 | $109,919,000 | 2,449,183 | 11.24 | 8.22 | 0 | 0.00 | 06-30-2021 |
CVRX, INC. | COM | 4 | $97,876,000 | 3,495,575 | 10.01 | 3,495,575 | +Inf | 06-30-2021 |